Katherine Elena Economy, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Cardiovascular | 18 | 2025 | 519 | 3.140 |
Why?
|
Delivery, Obstetric | 6 | 2020 | 945 | 1.250 |
Why?
|
Heart Diseases | 4 | 2021 | 2818 | 0.750 |
Why?
|
Pregnancy | 47 | 2025 | 30215 | 0.600 |
Why?
|
Pregnancy Complications, Hematologic | 3 | 2020 | 184 | 0.580 |
Why?
|
Hematologic Agents | 2 | 2019 | 38 | 0.530 |
Why?
|
Heart Valve Prosthesis | 4 | 2018 | 1464 | 0.490 |
Why?
|
Pre-Eclampsia | 5 | 2024 | 1256 | 0.480 |
Why?
|
Cesarean Section | 3 | 2020 | 1418 | 0.450 |
Why?
|
Pregnancy Outcome | 8 | 2021 | 2968 | 0.380 |
Why?
|
Tetralogy of Fallot | 4 | 2024 | 629 | 0.350 |
Why?
|
Labor, Obstetric | 1 | 2011 | 313 | 0.290 |
Why?
|
Abortion, Induced | 2 | 2024 | 471 | 0.290 |
Why?
|
Heart Defects, Congenital | 6 | 2025 | 4698 | 0.280 |
Why?
|
Thrombophilia | 2 | 2020 | 308 | 0.250 |
Why?
|
Gestational Age | 5 | 2020 | 3614 | 0.240 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 2599 | 0.240 |
Why?
|
Pregnancy Complications | 6 | 2018 | 2970 | 0.230 |
Why?
|
American Heart Association | 2 | 2020 | 1046 | 0.230 |
Why?
|
Cardiology | 1 | 2015 | 1700 | 0.220 |
Why?
|
Pregnancy Complications, Neoplastic | 3 | 2016 | 258 | 0.220 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1794 | 0.210 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2020 | 772 | 0.210 |
Why?
|
Societies, Medical | 1 | 2015 | 3950 | 0.210 |
Why?
|
Postnatal Care | 3 | 2020 | 274 | 0.190 |
Why?
|
Pericarditis | 1 | 2023 | 135 | 0.190 |
Why?
|
Tocolytic Agents | 1 | 2001 | 24 | 0.190 |
Why?
|
Female | 51 | 2025 | 396050 | 0.190 |
Why?
|
Prenatal Care | 4 | 2023 | 1157 | 0.190 |
Why?
|
Vascular Resistance | 1 | 2024 | 938 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 559 | 0.180 |
Why?
|
Breast Neoplasms | 4 | 2022 | 21064 | 0.170 |
Why?
|
Heart Rate, Fetal | 1 | 2020 | 77 | 0.170 |
Why?
|
Extraction, Obstetrical | 1 | 2019 | 28 | 0.160 |
Why?
|
Connective Tissue Diseases | 2 | 2019 | 284 | 0.160 |
Why?
|
Infant, Newborn | 9 | 2022 | 26337 | 0.160 |
Why?
|
Valsalva Maneuver | 1 | 2019 | 99 | 0.160 |
Why?
|
Registries | 1 | 2015 | 8320 | 0.160 |
Why?
|
Fibrinolytic Agents | 2 | 2020 | 2082 | 0.150 |
Why?
|
Amenorrhea | 1 | 2002 | 470 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2024 | 1092 | 0.150 |
Why?
|
Fetal Heart | 1 | 2020 | 281 | 0.150 |
Why?
|
Calcium Channel Blockers | 1 | 2001 | 685 | 0.150 |
Why?
|
Arrhythmias, Cardiac | 3 | 2019 | 2255 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1602 | 0.150 |
Why?
|
Blood Pressure | 1 | 2013 | 8532 | 0.150 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 468 | 0.140 |
Why?
|
Prospective Studies | 6 | 2023 | 54798 | 0.140 |
Why?
|
Maternal-Fetal Exchange | 2 | 2020 | 453 | 0.140 |
Why?
|
Heart Ventricles | 3 | 2024 | 3832 | 0.140 |
Why?
|
Pheochromocytoma | 2 | 2009 | 325 | 0.140 |
Why?
|
Breast Feeding | 2 | 2023 | 1363 | 0.140 |
Why?
|
Tachycardia, Supraventricular | 1 | 2020 | 271 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15645 | 0.140 |
Why?
|
Anesthetics | 1 | 2022 | 524 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2020 | 596 | 0.140 |
Why?
|
Pelvic Pain | 1 | 1999 | 300 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2024 | 840 | 0.130 |
Why?
|
Humans | 51 | 2025 | 765823 | 0.130 |
Why?
|
Vagina | 1 | 2002 | 848 | 0.130 |
Why?
|
Hemorrhage | 2 | 2020 | 3464 | 0.130 |
Why?
|
Electrocardiography | 4 | 2025 | 6408 | 0.130 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2015 | 34 | 0.130 |
Why?
|
Cardiovascular Agents | 2 | 2019 | 850 | 0.120 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 275 | 0.120 |
Why?
|
Pulmonary Edema | 4 | 2014 | 411 | 0.120 |
Why?
|
Ventricular Function, Right | 2 | 2024 | 629 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 307 | 0.120 |
Why?
|
Fetal Diseases | 1 | 2020 | 914 | 0.120 |
Why?
|
Abruptio Placentae | 1 | 2015 | 116 | 0.110 |
Why?
|
Fontan Procedure | 1 | 2020 | 805 | 0.110 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2009 | 731 | 0.110 |
Why?
|
Bioprosthesis | 1 | 2018 | 592 | 0.110 |
Why?
|
Uterus | 2 | 2012 | 660 | 0.110 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 165 | 0.110 |
Why?
|
Stroke Volume | 3 | 2024 | 5594 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2019 | 1438 | 0.110 |
Why?
|
Hypertension | 1 | 2013 | 8625 | 0.110 |
Why?
|
Metanephrine | 2 | 2009 | 25 | 0.110 |
Why?
|
Rheumatic Heart Disease | 1 | 2014 | 164 | 0.100 |
Why?
|
Laparoscopy | 2 | 2002 | 2037 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2025 | 81505 | 0.100 |
Why?
|
Cardiomyopathies | 2 | 2019 | 2066 | 0.100 |
Why?
|
Adult | 26 | 2025 | 223055 | 0.100 |
Why?
|
Mitral Valve Stenosis | 1 | 2014 | 342 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2121 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1029 | 0.090 |
Why?
|
Fetus | 2 | 2016 | 1878 | 0.090 |
Why?
|
Fetal Growth Retardation | 1 | 2015 | 591 | 0.090 |
Why?
|
Electric Countershock | 1 | 2014 | 536 | 0.090 |
Why?
|
Anesthesia | 1 | 2022 | 1581 | 0.090 |
Why?
|
Placenta | 1 | 2020 | 1725 | 0.090 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6544 | 0.090 |
Why?
|
Anticoagulants | 2 | 2016 | 4862 | 0.090 |
Why?
|
Hernia, Diaphragmatic | 1 | 2011 | 243 | 0.090 |
Why?
|
Thromboembolism | 1 | 2016 | 1001 | 0.080 |
Why?
|
Premature Birth | 1 | 2022 | 1829 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2014 | 729 | 0.080 |
Why?
|
Pilot Projects | 1 | 2023 | 8725 | 0.080 |
Why?
|
Ultrasonography, Prenatal | 5 | 2020 | 1772 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2018 | 1164 | 0.080 |
Why?
|
Heart Block | 1 | 2011 | 391 | 0.080 |
Why?
|
Pregnancy, High-Risk | 1 | 2010 | 121 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 1995 | 533 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2693 | 0.080 |
Why?
|
Aortic Coarctation | 1 | 2011 | 278 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9520 | 0.080 |
Why?
|
Aortic Valve | 1 | 2018 | 1966 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2532 | 0.080 |
Why?
|
Twins, Monozygotic | 1 | 2010 | 469 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2018 | 1564 | 0.070 |
Why?
|
Fetal Death | 3 | 2020 | 434 | 0.070 |
Why?
|
Lymph Node Excision | 1 | 2014 | 1260 | 0.070 |
Why?
|
Mastectomy | 1 | 2016 | 1848 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3931 | 0.070 |
Why?
|
Transposition of Great Vessels | 1 | 2011 | 581 | 0.070 |
Why?
|
Puerperal Disorders | 1 | 2009 | 304 | 0.070 |
Why?
|
Electrodes, Implanted | 1 | 2011 | 834 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2956 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5937 | 0.070 |
Why?
|
Mammaplasty | 1 | 2016 | 1264 | 0.060 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2024 | 0.060 |
Why?
|
Risk Factors | 9 | 2020 | 74853 | 0.060 |
Why?
|
Pacemaker, Artificial | 1 | 2011 | 829 | 0.060 |
Why?
|
Obstetric Labor, Premature | 2 | 2010 | 268 | 0.060 |
Why?
|
Ventricular Remodeling | 1 | 2013 | 1273 | 0.060 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2011 | 531 | 0.060 |
Why?
|
Aminopeptidases | 1 | 2024 | 113 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2771 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10723 | 0.050 |
Why?
|
Ultrasonography | 2 | 2014 | 5995 | 0.050 |
Why?
|
Infant | 2 | 2023 | 36375 | 0.050 |
Why?
|
Colchicine | 1 | 2023 | 255 | 0.050 |
Why?
|
MEDLINE | 1 | 2001 | 120 | 0.050 |
Why?
|
Postpartum Period | 2 | 2024 | 1196 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2012 | 36542 | 0.050 |
Why?
|
Infant Mortality | 2 | 2023 | 752 | 0.050 |
Why?
|
Nifedipine | 1 | 2001 | 220 | 0.050 |
Why?
|
Pregnancy, Prolonged | 1 | 2000 | 9 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2014 | 2788 | 0.050 |
Why?
|
Uterine Contraction | 1 | 2001 | 90 | 0.050 |
Why?
|
Leiomyoma | 1 | 2006 | 644 | 0.050 |
Why?
|
Comorbidity | 1 | 2015 | 10570 | 0.040 |
Why?
|
Echocardiography | 3 | 2020 | 5042 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 3 | 2024 | 3673 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 346 | 0.040 |
Why?
|
Tachycardia | 2 | 2014 | 597 | 0.040 |
Why?
|
Microvessels | 1 | 2024 | 589 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2022 | 632 | 0.040 |
Why?
|
Labor, Induced | 1 | 2000 | 153 | 0.040 |
Why?
|
Microcirculation | 1 | 2024 | 1279 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1039 | 0.040 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2020 | 140 | 0.040 |
Why?
|
Pelvic Inflammatory Disease | 1 | 1999 | 95 | 0.040 |
Why?
|
Taxoids | 1 | 2022 | 664 | 0.040 |
Why?
|
Heart Failure | 2 | 2021 | 11838 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2023 | 65223 | 0.040 |
Why?
|
Teratogens | 1 | 2019 | 120 | 0.040 |
Why?
|
Chemoprevention | 1 | 2020 | 327 | 0.040 |
Why?
|
Periodicity | 1 | 1999 | 347 | 0.040 |
Why?
|
Young Adult | 7 | 2024 | 59849 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2024 | 1376 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 2 | 2009 | 587 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 1425 | 0.030 |
Why?
|
Cervix Uteri | 1 | 2000 | 575 | 0.030 |
Why?
|
Radiography | 3 | 2014 | 6941 | 0.030 |
Why?
|
Medical Records | 1 | 2002 | 1409 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 280 | 0.030 |
Why?
|
Cohort Studies | 4 | 2016 | 41643 | 0.030 |
Why?
|
Standard of Care | 1 | 2019 | 567 | 0.030 |
Why?
|
Alkalosis, Respiratory | 1 | 2014 | 20 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39226 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 960 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1432 | 0.030 |
Why?
|
Regression Analysis | 1 | 2023 | 6320 | 0.030 |
Why?
|
Methylene Blue | 1 | 2014 | 157 | 0.030 |
Why?
|
Risk Assessment | 4 | 2020 | 24278 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2269 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3096 | 0.030 |
Why?
|
Breast Implants | 1 | 2016 | 411 | 0.030 |
Why?
|
Cardiac Volume | 1 | 2013 | 196 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3584 | 0.020 |
Why?
|
Adolescent | 5 | 2020 | 88794 | 0.020 |
Why?
|
Dyspnea | 2 | 2009 | 1351 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3135 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 562 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2112 | 0.020 |
Why?
|
Endometriosis | 1 | 1999 | 869 | 0.020 |
Why?
|
Recurrence | 1 | 2023 | 8506 | 0.020 |
Why?
|
Menotropins | 1 | 1990 | 41 | 0.020 |
Why?
|
Medicaid | 1 | 2023 | 2832 | 0.020 |
Why?
|
Perinatal Mortality | 1 | 2010 | 103 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2002 | 14644 | 0.020 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2009 | 170 | 0.020 |
Why?
|
Thoracotomy | 1 | 2011 | 374 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2024 | 18970 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2188 | 0.020 |
Why?
|
Fetofetal Transfusion | 1 | 2010 | 119 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2009 | 2136 | 0.020 |
Why?
|
Catecholamines | 1 | 2009 | 385 | 0.020 |
Why?
|
Acute Disease | 1 | 1999 | 7237 | 0.020 |
Why?
|
United States | 3 | 2023 | 72896 | 0.020 |
Why?
|
Hemodynamics | 1 | 2019 | 4188 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2010 | 447 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2965 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3199 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1603 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 1990 | 731 | 0.020 |
Why?
|
Male | 3 | 2020 | 363740 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6545 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 1990 | 826 | 0.020 |
Why?
|
Anesthesia, Obstetrical | 1 | 2010 | 234 | 0.020 |
Why?
|
Maternal Mortality | 1 | 2010 | 310 | 0.020 |
Why?
|
Maternal Age | 1 | 2010 | 804 | 0.020 |
Why?
|
Parity | 1 | 2010 | 930 | 0.020 |
Why?
|
Stillbirth | 1 | 2010 | 381 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12966 | 0.020 |
Why?
|
Pericardium | 1 | 2011 | 679 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9081 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15881 | 0.020 |
Why?
|
Ovary | 1 | 1990 | 957 | 0.020 |
Why?
|
Endometrial Neoplasms | 1 | 1995 | 1379 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2001 | 10383 | 0.010 |
Why?
|
Safety Management | 1 | 2010 | 762 | 0.010 |
Why?
|
Chronic Disease | 1 | 1999 | 9355 | 0.010 |
Why?
|
Infertility, Female | 1 | 1990 | 763 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3251 | 0.010 |
Why?
|
Lung | 2 | 2014 | 10031 | 0.010 |
Why?
|
Hemoglobins | 1 | 2009 | 1529 | 0.010 |
Why?
|
Prognosis | 2 | 2014 | 29915 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1995 | 2041 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1276 | 0.010 |
Why?
|
Headache | 1 | 2009 | 1261 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15398 | 0.010 |
Why?
|
Autoantibodies | 1 | 1990 | 2112 | 0.010 |
Why?
|
Abortion, Spontaneous | 1 | 2006 | 535 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15832 | 0.010 |
Why?
|
Administration, Intravaginal | 1 | 2000 | 149 | 0.010 |
Why?
|
Pregnancy, Multiple | 1 | 2000 | 216 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11205 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14062 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40109 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1995 | 4903 | 0.010 |
Why?
|
Length of Stay | 1 | 2011 | 6485 | 0.010 |
Why?
|
Endosonography | 1 | 2000 | 626 | 0.010 |
Why?
|
Neoplasms | 1 | 2024 | 22349 | 0.010 |
Why?
|
Middle Aged | 4 | 2018 | 223016 | 0.010 |
Why?
|
Water | 1 | 2000 | 1417 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2016 | 15794 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21501 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8039 | 0.010 |
Why?
|
Animals | 1 | 2001 | 168730 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2000 | 7416 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 3802 | 0.000 |
Why?
|
Estradiol | 1 | 1990 | 1946 | 0.000 |
Why?
|
Fertilization in Vitro | 1 | 1990 | 1301 | 0.000 |
Why?
|
Child | 1 | 2006 | 80509 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1990 | 11033 | 0.000 |
Why?
|